Source:http://linkedlifedata.com/resource/pubmed/id/16908955
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2006-8-15
|
pubmed:abstractText |
We investigated the lipid lowering and anti-atherosclerotic effects of atorvastatin in patients with hypercholesterolemia. Thirty patients were given atorvastatin 10 mg daily, and assessed for serum lipids, intima-media thickness (IMT), and brachial-ankle pulse wave velocity (ba-PWV) at the baseline, 6 months, and 12 months. Remnant-like particle-cholesterol (RLP-C), lipoprotein (a)(Lp(a)), and high-sensitivity C-reactive protein (hs-CRP) were measured in some patients at the baseline and at 6 months. Total cholesterol, triglyceride and low-density lipoprotein cholesterol were significantly decreased by 32%, 23% and 44% at 6 months, respectively, and these effects were sustained at 12 months. There was no change in high-density lipoprotein cholesterol. IMT at the baseline was 0.88 +/- 0.16 mm and decreased to 0.76 +/- 0.13 mm at 6 months, remaining at 0.75 +/- 0.12 mm at 12 months. We did not observe any significant changes in ba-PWV. RLP-C and hs-CRP were significantly reduced from 7.3 +/- 10.8 mg/dL to 4.3 +/- 5.3 mg/dL and 0.075 +/- 0.065 mg/dL to 0.039 +/- 0.043 mg/dL at 6 months, respectively. There was no change in Lp(a). The observed decrease in IMT suggests that atorvastatin possibly improves atherosclerosis, in addition to the significant reduction of serum lipids.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles,
http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1340-3478
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
216-9
|
pubmed:meshHeading |
pubmed-meshheading:16908955-Aged,
pubmed-meshheading:16908955-Anticholesteremic Agents,
pubmed-meshheading:16908955-Atherosclerosis,
pubmed-meshheading:16908955-C-Reactive Protein,
pubmed-meshheading:16908955-Female,
pubmed-meshheading:16908955-Heptanoic Acids,
pubmed-meshheading:16908955-Humans,
pubmed-meshheading:16908955-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:16908955-Hypercholesterolemia,
pubmed-meshheading:16908955-Inflammation,
pubmed-meshheading:16908955-Lipids,
pubmed-meshheading:16908955-Male,
pubmed-meshheading:16908955-Middle Aged,
pubmed-meshheading:16908955-Pyrroles,
pubmed-meshheading:16908955-Time Factors,
pubmed-meshheading:16908955-Tunica Intima,
pubmed-meshheading:16908955-Tunica Media
|
pubmed:year |
2006
|
pubmed:articleTitle |
The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia.
|
pubmed:affiliation |
Division of Cardiology, Niigata University Graduate School of Medical & Dental Sciences, Niigata, Japan. k-ozaki@hosp.niigata.niigata.jp
|
pubmed:publicationType |
Journal Article
|